{"id":"W2981445333","doi":"10.1093/eurheartj/ehz745.0116","title":"4112Risk factors and clinical outcomes in chronic CAD and PAD: an analysis of the randomized, double-blind COMPASS trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Aspirin; Rivaroxaban; Internal medicine; Risk factor; Coronary artery disease; Antithrombotic; Hazard ratio; Body mass index; Stroke (engine); Cardiology; Surgery; Warfarin; Confidence interval; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006593906,0.002185203,0.005003065,0.0005852791,0.0005152244,0.001682808,0.0008873753,0.001822292,0.00702716],"category_scores_gemma":[0.006548037,0.0008059093,0.004942155,0.0008062184,0.001597395,0.001171812,0.0009213111,0.001862288,0.0007348883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005458213,"about_ca_system_score_gemma":0.001357213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001053276,"about_ca_topic_score_gemma":0.001330708,"domain_scores_codex":[0.9952329,0.003418194,0.0003382715,0.0004760299,0.0002859029,0.0002486629],"domain_scores_gemma":[0.9952376,0.001655428,0.001355288,0.0006429643,0.000423837,0.0006849295],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9916824,0.0004988313,0.001619148,0.0003826341,0.002878258,0.00002165577,0.00001870648,0.0001317618,0.0002888467,0.00007594621,0.0004103112,0.001991521],"study_design_scores_gemma":[0.9754122,0.01467277,0.005570705,0.00006232709,0.00285753,0.00003833358,0.00002145792,0.0004342319,0.0001138856,0.0002396391,0.0005543166,0.00002259817],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9813881,0.009228439,0.0009828941,0.0008026865,0.001026406,0.002271508,0.002393576,0.0001250581,0.001781438],"genre_scores_gemma":[0.98502,0.002807102,0.00147693,0.00106845,0.001302985,0.003060907,0.002882635,0.00003700153,0.002344053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00702716,"threshold_uncertainty_score":0.03487235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06807670208019517,"score_gpt":0.3657650004787879,"score_spread":0.2976882983985927,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}